share_log

Leerink Partners Maintains HCA Healthcare(HCA.US) With Buy Rating, Raises Target Price to $460

Futu News ·  Oct 28 21:34  · Ratings

Leerink Partners analyst Whit Mayo maintains $HCA Healthcare (HCA.US)$ with a buy rating, and adjusts the target price from $396 to $460.

According to TipRanks data, the analyst has a success rate of 50.0% and a total average return of 3.9% over the past year.

AnalystRecentRatingAutoNews_206673_20241028_476bf8a9b63b7679cda2c2eb873158d92cc97b57_1730122286852611_nn_en

Furthermore, according to the comprehensive report, the opinions of $HCA Healthcare (HCA.US)$'s main analysts recently are as follows:

  • The anticipated disturbances from hurricanes were factored in, however, a more notable revelation was the projection for EBITDA and EPS in 2025 falling short of market expectations, interrupting a sequence of strong beat and raise events. Despite the attractive nature of the recent 9% stock dip, there is a belief that a phase of stock consolidation might be forthcoming.

  • HCA Healthcare's Q3 outcomes have successfully navigated through the negative impacts of hurricanes, a trend which is anticipated to persist into Q4 and potentially lead to FY2024 guidance aligning with the lower spectrum of projections. Even with ongoing challenges from hurricanes, the company's leadership anticipates earnings growth in 2025 to meet or exceed their longstanding objectives, bolstered by an admissions growth forecast of 3%-4%, which is considered above the usual trend.

  • Following the release of 3Q24 results, there has been an update to the financial model for HCA Healthcare. Despite high expectations prior to the third quarter results, the company's underlying performance remained robust, demonstrated by a 7.1% increase in same-store revenues, compared to the third quarter of the previous year's 7.9%.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment